• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Clinical Outcomes Five Years after POEM for Treatment of Esophageal Motility Disorders

Clinical Outcomes Five Years after POEM for Treatment of Esophageal Motility Disorders

Ezra N Teitelbaum, MD, Christy M Dunst, MD, Kevin M Reavis, MD, Ahmed M Sharata, MD, Marc A Ward, MD, Steven R DeMeester, MD, Lee L Swanstrom, MD. The Oregon Clinic

Introduction: Peroral endoscopic myotomy (POEM) is a novel procedure for the treatment of achalasia and other esophageal motility disorders. Excellent short-to-medium term results have been reported, but no study has yet described outcomes at 5 years. In this study we examined the long-term clinical outcomes of the initial POEM patients in our series.

Methods: All patients from a single-center who underwent POEM from October 2010 to February 2012 were included. Patients were contacted to obtain current symptom scores (Eckardt and GerdQ) and encouraged to undergo repeat EGD. Symptomatic success was defined as an Eckardt score ≤3 and freedom from reintervention.

Results: Thirty-six patients underwent POEM during the study period. Three were deceased (all unrelated to achalasia) and 6 were lost to follow-up, leaving 27 patients in the study population. Fourteen were female and the median age was 67. Twenty-two patients had achalasia type I or II and 5 had EGJ outflow obstruction with partially preserved peristalsis. Eckardt scores at a median follow-up of 5 years (range 54-70 months) were significantly improved from preoperatively (mean 1.6 vs. 6.3, p<0.001) and the current Eckardt score was ≤3 in 23 patients (85%). Reintervention was necessary in 2 patients (7%): a laparoscopic Heller myotomy for persistent dysphagia in one patient and an endoscopic proximal myotomy extension to treat spastic chest pain in a second. Both reinterventions were successful, with current Eckardt scores of ≤2 in those patients. Overall, 21 patients (78%) were treatment successes, with both an Eckardt score ≤3 and freedom from reintervention at 5 years. Of the patients with prospectively collected Eckardt scores at 6 months, 2 and 5 years (n=20), symptoms were dramatically improved at 6 months (mean 0.6 vs. 6.7 preoperatively) and maintained at 2 years (mean 0.8), but there was a trend towards worsening symptoms at 5 years (mean 1.6, p=0.06 vs. at 2 years). At 5 years, 6 patients (22%) had symptoms suggestive of gastroesophageal reflux (GerdQ>7) and 8 (30%) were taking daily anti-secretory medications. Eleven patients underwent repeat EGD at 5 years, with 2 (18%) showing mild esophagitis (1 LA A, 1 LA B) and 1 with new Barrett’s esophagus without dysplasia.

Conclusions: In this series, representing the longest reported follow-up to date, POEM remains an effective treatment for esophageal motility disorders out to 5 years in most patients. There may be slight symptomatic regression over time in some patients but the need for reintervention was rare.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 80636

Program Number: S092

Presentation Session: Plenary 1

Presentation Type: Podium

83

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals